Avidan N, Sieck T G, Blank K J
Department of Pathology and Laboratory Medicine, Allegheney University of the Health Sciences, Philadelphia, Pennsylvania 19102, USA.
Clin Immunol Immunopathol. 1997 Dec;85(3):282-8. doi: 10.1006/clin.1997.4447.
Previous studies from this laboratory have demonstrated that E-55+MuLV-infected BALB/c-H-2k (BALB.K) mice progress to develop thymic lymphoma about 7 months after infection whereas infected C57BL/10-H-2k (B10.BR) mice are long-term nonprogressors that fail to develop disease even after 2 years of infection. Both resistant long-term nonprogressor (B10.BR) and progressor (BALB.K) mice generate an early immune response that results in a dramatic decrease in the number of virus-infected cells. Despite this early immune response, mice from both strains become persistently infected. However, resistant B10.BR mice also demonstrate a late T-cell-mediated response that may be causally related to long-term nonprogression whereas susceptible BALB.K mice fail to demonstrate this late T-cell response. In the present studies, the T-cell subsets involved in the effective early immune response in both B10.BR and BALB.K mice as well as the late T-cell response in B10.BR mice were determined by in vivo antibody-mediated depletion. Results from these studies demonstrate that during the early acute phase of infection, elimination of CD4+ T cells ablated the ability of both BALB.K and B10.BR mice to decrease the burden of virus-infected cells. However, elimination of CD8+ T cells ablated this result in BALB.K but not B10.BR mice. Thus, despite the fact that both immunocompetent B10.BR and BALB.K mice are able to decrease the number of virus-infected cells during the early acute phase of infection, there is a difference in the T-cell subsets that mediate this effect in these strains of mice. In addition, characterization of the late immune response that keeps virus at very low levels during the persistent stage of virus infection in resistant B10.BR mice demonstrated that simultaneous elimination of both CD4+ and CD8+ T cells allowed the emergence of virus-infected cells whereas the elimination of either subset alone showed no effect compared to untreated control mice that are immunologically intact. Since B10.BR and BALB.K are identical with respect to their H-2k-haplotypes, it appears that the differences between these strains with respect to the generation of effective early and late anti-virus immune responses are regulated by a non-H-2-linked gene(s).
该实验室之前的研究表明,感染E-55 + MuLV的BALB/c-H-2k(BALB.K)小鼠在感染后约7个月会发展为胸腺淋巴瘤,而感染的C57BL/10-H-2k(B10.BR)小鼠是长期无进展者,即使在感染2年后也不会发病。具有抗性的长期无进展者(B10.BR)小鼠和进展者(BALB.K)小鼠都会产生早期免疫反应,导致病毒感染细胞数量大幅减少。尽管有这种早期免疫反应,但这两种品系的小鼠都会持续感染。然而,具有抗性的B10.BR小鼠还表现出一种晚期T细胞介导的反应,这可能与长期无进展存在因果关系,而易感的BALB.K小鼠则未表现出这种晚期T细胞反应。在本研究中,通过体内抗体介导的清除法确定了参与B10.BR和BALB.K小鼠有效早期免疫反应的T细胞亚群以及B10.BR小鼠的晚期T细胞反应。这些研究结果表明,在感染的早期急性期,清除CD4 + T细胞消除了BALB.K和B10.BR小鼠降低病毒感染细胞负担的能力。然而,清除CD8 + T细胞消除了BALB.K小鼠的这一结果,但对B10.BR小鼠没有影响。因此,尽管具有免疫能力的B10.BR和BALB.K小鼠在感染的早期急性期都能够减少病毒感染细胞的数量,但在介导这种效应的T细胞亚群方面,这两种品系的小鼠存在差异。此外,对在具有抗性的B10.BR小鼠病毒感染持续阶段将病毒维持在极低水平的晚期免疫反应的特征分析表明,同时清除CD4 +和CD8 + T细胞会使病毒感染细胞出现,而单独清除任何一个亚群与免疫功能完整的未处理对照小鼠相比均无影响。由于B10.BR和BALB.K在其H-2k单倍型方面是相同的,因此这些品系在产生有效的早期和晚期抗病毒免疫反应方面的差异似乎是由一个非H-2连锁基因调控的。